Allcutis Research, Inc
Portsmouth, New Hampshire 03801
0 studies enrolling now · 1 studies all time
What they study most
Atopic Dermatitis
Studies at this site
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
— Completed